StonvexLoading…
StonvexStonvexStonvexCore line items from RSVR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $158.71M | $144.86M | $122.29M | $107.84M |
Operating Income | $35.06M | $24.58M | $21.06M | $19.35M |
Net Income | $7.75M | $644.94K | $2.54M | $13.08M |
EPS (Diluted) | $0.12 | $0.01 | $0.04 | $0.22 |
Total Assets | $865.13M | $783.53M | $754.08M | $684.27M |
Total Liabilities | $498.93M | $429.05M | $404.42M | $336.82M |
Cash & Equivalents | $21.39M | $18.13M | $14.90M | $17.81M |
Free Cash Flow OCF − CapEx | $45.20M | $35.97M | $30.80M | $12.28M |
Shares Outstanding | 65.24M | 64.83M | 64.44M | 64.15M |